Low-grade inflammation in symptomatic knee osteoarthritis: Prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers

Arthritis and Rheumatology

Volumn 67, Issue 11, 2015, Pages 2905-2915

  Attur, Mukundan ^a   Krasnokutsky, Svetlana ^a   Statnikov, Alexander ^a   Samuels, Jonathan ^a   Li, Zhiguo ^a   Friese, Olga ^b   Hellio Le Graverand Gastineau, Marie Pierre ^b   Rybak, Leon ^a   Kraus, Virginia B ^c   Jordan, Joanne M ^d   Aliferis, Constantin F ^a   Abramson, Steven B ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PFIZER INC   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXYICOSATETRAENOIC ACID; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; SYNTHETASE; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; 15-HYDROXY-5,8,11,13-EICOSATETRAENOIC ACID; BIOLOGICAL MARKER; HYDROXYICOSATETRAENOIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FATTY ACID BLOOD LEVEL; FEMALE; GENE EXPRESSION; HUMAN; INFLAMMATION; JOINT CAVITY; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; LEUKOCYTE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; OUTCOME ASSESSMENT; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTAGLANDIN BLOOD LEVEL; QUANTITATIVE ASSAY; RNA ANALYSIS; X RAY FILM; AGED; BLOOD; DIAGNOSTIC IMAGING; KNEE; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RADIOGRAPHY;

AGED; BIOMARKERS; DINOPROSTONE; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROXYEICOSATETRAENOIC ACIDS; INFLAMMATION; KNEE JOINT; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PROGNOSIS; PROSPECTIVE STUDIES; RADIOGRAPHY;

EID: 84946082245     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39279     Document Type: Article

References (58)

1. Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyere O, Chapurlat R, et al., Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis 2013; 72: 1756-63.
2. Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation: United States, 2010-2012. MMWR Morb Mortal Wkly Rep 2013; 62: 869-73.
3. Abramson SB, Attur M, Yazici Y., Prospects for disease modification in osteoarthritis. Nat Clin Pract Rheumatol 2006; 2: 304-12.
4. Attur M, Belitskaya-Levy I, Oh C, Krasnokutsky S, Greenberg J, Samuels J, et al., Increased interleukin-1β gene expression in peripheral blood leukocytes is associated with increased pain and predicts risk for progression of symptomatic knee osteoarthritis. Arthritis Rheum 2011; 63: 1908-17.
5. Berenbaum F., Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013; 21: 16-21.
6. Amin AR, Attur M, Patel RN, Thakker GD, Marshall PJ, Rediske J, et al., Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage: influence of nitric oxide. J Clin Invest 1997; 99: 1231-7.
7. Krasnokutsky S, Belitskaya-Levy I, Bencardino J, Samuels J, Attur M, Regatte R, et al., Quantitative magnetic resonance imaging evidence of synovial proliferation is associated with radiographic severity of knee osteoarthritis. Arthritis Rheum 2011; 63: 2983-91.
8. Guermazi A, Hayashi D, Roemer FW, Zhu Y, Niu J, Crema MD, et al., Synovitis in knee osteoarthritis assessed by contrast-enhanced magnetic resonance imaging (MRI) is associated with radiographic tibiofemoral osteoarthritis and MRI-detected widespread cartilage damage: the MOST study. J Rheumatol 2014; 41: 501-8.
9. Amin S, LaValley MP, Guermazi A, Grigoryan M, Hunter DJ, Clancy M, et al., The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis Rheum 2005; 52: 3152-9.
10. Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, et al., Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum 1986; 29: 1039-49.
11. Kellgren JH, Lawrence JS., Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502.
12. Malfait AM, Seymour AB, Gao F, Tortorella MD, Le Graverand-Gastineau MP, Wood LS, et al., A role for PACE4 in osteoarthritis pain: evidence from human genetic association and null mutant phenotype. Ann Rheum Dis 2012; 71: 1042-8.
13. Goekoop RJ, Kloppenburg M, Kroon HM, Frolich M, Huizinga TW, Westendorp RG, et al., Low innate production of interleukin-1β and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthritis Cartilage 2010; 18: 942-7.
14. Nemirovskiy OV, Dufield DR, Sunyer T, Aggarwal P, Welsch DJ, Mathews WR., Discovery and development of a type II collagen neoepitope (TIINE) biomarker for matrix metalloproteinase activity: from in vitro to in vivo. Anal Biochem 2007; 361: 93-101.
15. Li WW, Nemirovskiy O, Fountain S, Rodney MW, Szekely-Klepser G., Clinical validation of an immunoaffinity LC-MS/MS assay for the quantification of a collagen type II neoepitope peptide: a biomarker of matrix metalloproteinase activity and osteoarthritis in human urine. Anal Biochem 2007; 369: 41-53.
16. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al., Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4: 249-64.
17. Irizarry RA, Wu Z, Jaffee HA., Comparison of Affymetrix GeneChip expression measures. Bioinformatics 2006; 22: 789-94.
18. Fawcett T., An introduction to ROC analysis. Pattern Recognit Lett 2006; 27: 861-74.
19. DeLong ER, DeLong DM, Clarke-Pearson DL., Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988; 44: 837-45.
20. Benjamini Y, Hochberg Y., Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B 1995; 57: 289-300.
21. Emrani PS, Katz JN, Kessler CL, Reichmann WM, Wright EA, McAlindon TE, et al., Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis. Osteoarthritis Cartilage 2008; 16: 873-82.
22. Cooper C, Adachi JD, Bardin T, Berenbaum F, Flamion B, Jonsson H, et al., How to define responders in osteoarthritis. Curr Med Res Opin 2013; 29: 719-29.
23. Vapnik VN., Statistical learning theory. New York: Wiley; 1998.
24. Statnikov A, Tsamardinos I, Dosbayev Y, Aliferis CF., GEMS: a system for automated cancer diagnosis and biomarker discovery from microarray gene expression data. Int J Med Inform 2005; 74: 491-503.
25. Braga-Neto UM, Dougherty ER., Is cross-validation valid for small-sample microarray classification? Bioinformatics 2004; 20: 374-80.
26. Statnikov A, Aliferis CF, Hardin DP, Guyon I., A gentle introduction to support vector machines in biomedicine. Vol. 1. Theory and methods. Singapore: World Scientific Publishing; 2011.
27. Statnikov A, Aliferis CF, Hardin DP, Guyon I., A gentle introduction to support vector machines in biomedicine. Vol. 2. Case studies and benchmarks. Singapore: World Scientific Publishing; 2013.
28. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW., Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833-40.
29. Hunter DJ, Niu J, Felson DT, Harvey WF, Gross KD, McCree P, et al., Knee alignment does not predict incident osteoarthritis: the Framingham Osteoarthritis Study. Arthritis Rheum 2007; 56: 1212-8.
30. Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, et al., Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage 2006; 14: 723-7.
31. 2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders. J Oral Maxillofac Surg 2000; 58: 180-6.
32. Morton AJ, Campbell NB, Gayle JM, Redding WR, Blikslager AT., Preferential and non-selective cyclooxygenase inhibitors reduce inflammation during lipopolysaccharide-induced synovitis. Res Vet Sci 2005; 78: 189-92.
33. 2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol 2008; 181: 5082-8.
34. De Boer TN, Huisman AM, Polak AA, Niehoff AG, van Rinsum AC, Saris D, et al., The chondroprotective effect of selective COX-2 inhibition in osteoarthritis: ex vivo evaluation of human cartilage tissue after in vivo treatment. Osteoarthritis Cartilage 2009; 17: 482-8.
35. Gosset M, Pigenet A, Salvat C, Berenbaum F, Jacques C., Inhibition of matrix metalloproteinase-3 and -13 synthesis induced by IL-1β in chondrocytes from mice lacking microsomal prostaglandin E synthase-1. J Immunol 2010; 185: 6244-52.
36. Crofford LJ, Lipsky PE, Brooks P, Abramson SB, Simon LS, van de Putte LB., Basic biology and clinical application of specific cyclooxygenase-2 inhibitors. Arthritis Rheum 2000; 43: 4-13.
37. 4 synthase activities in human chondrocytes: transcellular biosynthesis of leukotrienes during granulocyte-chondrocyte interaction. Arthritis Rheum 1998; 41: 1645-51.
38. Gheorghe KR, Korotkova M, Catrina AI, Backman L, af Klint E, Claesson HE, et al., Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids. Arthritis Res Ther 2009; 11: R83.
39. Burhop KE, Selig WM, Malik AB., Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema. Circ Res 1988; 62: 687-98.
40. Kronke G, Katzenbeisser J, Uderhardt S, Zaiss MM, Scholtysek C, Schabbauer G, et al., 12/15-lipoxygenase counteracts inflammation and tissue damage in arthritis. J Immunol 2009; 183: 3383-9.
41. Tchetina EV, Poole AR, Zaitseva EM, Sharapova EP, Kashevarova NG, Taskina EA, et al., Differences in mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity. Arthritis 2013; 2013: 461486.
42. Ramos YF, Bos SD, Lakenberg N, Bohringer S, den Hollander WJ, Kloppenburg M, et al., Genes expressed in blood link osteoarthritis with apoptotic pathways. Ann Rheum Dis 2014; 73: 1844-53.
43. Sohn DH, Sokolove J, Sharpe O, Erhart JC, Chandra PE, Lahey LJ, et al., Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther 2012; 14: R7.
44. Hirohata S, Yanagida T, Tomita T, Yoshikawa H., Enhanced expression of mRNA for interleukin 6 and tumor necrosis factor-alpha in CD34+ cells of the bone marrow in osteoarthritis [abstract]. Arthritis Rheum 2011; 63 Suppl: S694.
45. Stannus O, Jones G, Cicuttini F, Parameswaran V, Quinn S, Burgess J, et al., Circulating levels of IL-6 and TNF-α are associated with knee radiographic osteoarthritis and knee cartilage loss in older adults. Osteoarthritis Cartilage 2010; 18: 1441-7.
46. Benito MJ, Veale DJ, FitzGerald O, van den Berg WB, Bresnihan B., Synovial tissue inflammation in early and late osteoarthritis. Ann Rheum Dis 2005; 64: 1263-7.
47. Pessler F, Dai L, Diaz-Torne C, Gomez-Vaquero C, Paessler ME, Zheng DH, et al., The synovitis of "non-inflammatory" orthopaedic arthropathies: a quantitative histological and immunohistochemical analysis. Ann Rheum Dis 2008; 67: 1184-7.
48. Honsawek S, Yuktanandana P, Tanavalee A, Chirathaworn C, Anomasiri W, Udomsinprasert W, et al., Plasma and synovial fluid connective tissue growth factor levels are correlated with disease severity in patients with knee osteoarthritis. Biomarkers 2012; 17: 303-8.
49. Kyostio-Moore S, Nambiar B, Hutto E, Ewing PJ, Piraino S, Berthelette P, et al., STR/ort mice, a model for spontaneous osteoarthritis, exhibit elevated levels of both local and systemic inflammatory markers. Comp Med 2011; 61: 346-55.
50. Colitti M, Gaspardo B, Della PA, Scaini C, Stefanon B., Transcriptome modification of white blood cells after dietary administration of curcumin and non-steroidal anti-inflammatory drug in osteoarthritic affected dogs. Vet Immunol Immunopathol 2012; 147: 136-46.
51. Denoble AE, Huffman KM, Stabler TV, Kelly SJ, Hershfield MS, McDaniel GE, et al., Uric acid is a danger signal of increasing risk for osteoarthritis through inflammasome activation. Proc Natl Acad Sci U S A 2011; 108: 2088-93.
52. Daghestani HN, Pieper CF, Kraus VB., Soluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritis. Arthritis Rheumatol 2015; 67: 956-65.
53. Zhou ZY, Liu YK, Chen HL, Liu F., Body mass index and knee osteoarthritis risk: a dose-response meta-analysis. Obesity (Silver Spring) 2014; 22: 2180-5.
54. Le Graverand MP, Brandt K, Mazzuca SA, Raunig D, Vignon E., Progressive increase in body mass index is not associated with a progressive increase in joint space narrowing in obese women with osteoarthritis of the knee. Ann Rheum Dis 2009; 68: 1734-8.
55. Niu J, Zhang YQ, Torner J, Nevitt M, Lewis CE, Aliabadi P, et al., Is obesity a risk factor for progressive radiographic knee osteoarthritis? Arthritis Rheum 2009; 61: 329-35.
56. Yusuf E, Bijsterbosch J, Slagboom PE, Rosendaal FR, Huizinga TW, Kloppenburg M., Body mass index and alignment and their interaction as risk factors for progression of knees with radiographic signs of osteoarthritis. Osteoarthritis Cartilage 2011; 19: 1117-22.
57. Wu X, Kondragunta V, Kornman KS, Wang HY, Duff GW, Renner JB, et al., IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort. Osteoarthritis Cartilage 2013; 21: 930-8.
58. Karsdal MA, Bihlet A, Byrjalsen I, Alexandersen P, Ladel C, Michaels M, et al., OA phenotypes, rather than disease stage, drive structural progression-identification of structural progressors from 2 phase III randomized clinical studies with symptomatic knee OA. Osteoarthritis Cartilage 2015; 23: 550-8.